5 ms·
This paper further supports the fact that naturally acquired immunity to SARS-CoV-2 is 1) robust and 2) durable. 1) Robust means the immune response recognizes
by criticaltinker 5y ago
This paper further supports the fact that naturally acquired immunity to SARS-CoV-2 is 1) robust and 2) durable.
1) Robust means the immune response recognizes many different parts of the virus.
2) Durable means the immune response remains detectable - and likely effective at protecting the individual - for a long period of time.
A robust immune response is important because it provides a certain degree of protection against variants of the virus.
This robustness is why some people hypothesize that natural immunity provides better protection than vaccination - however this hypothesis has not been conclusively proven in the literature yet. If you're aware of primary sources that say otherwise please share them.
For now, all available evidence strongly suggests that individuals with naturally acquired immunity are at least equally well protected as individuals who have been vaccinated. Here are a couple more supporting references [1][2].
As a final point - in the literature there is some evidence & concern that the current mRNA vaccines induce an immune response which is highly targeted toward the spike protein [3]. When combined with mass vaccination campaigns, this creates tremendous selective pressure that can further enhance the fitness of the virus, and lead to increasingly infectious or virulent variants [3][4][5][6].
It's clear that vaccination poses little additional risk - but also little benefit - to previously infected individuals, and consequently our vaccination campaigns should be highly targeted toward vulnerable demographics to reap the most benefits and minimize the risks to public health.
[1] SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
https://www.nature.com/articles/s41586-021-03647-4.pdf https://www.nature.com/articles/s41586-021-03647-4.pdf
[2] Necessity of COVID-19 vaccination in previously infected individuals
https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v3.full.pdf https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v...
[3] Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein
https://pubmed.ncbi.nlm.nih.gov/33909660/ https://pubmed.ncbi.nlm.nih.gov/33909660/
[4] SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
https://science.sciencemag.org/content/early/2021/06/30/science.abi7994 https://science.sciencemag.org/content/early/2021/06/30/scie...
[5] mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
https://www.nature.com/articles/s41586-021-03324-6 https://www.nature.com/articles/s41586-021-03324-6
[6] Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens
https://journals.plos.org/plosbiology/article?id=10.1371%2Fjournal.pbio.1002198 https://journals.plos.org/plosbiology/article?id=10.1371%2Fj...
- bmer 5y agoReference [1] is applicable to how our body handles an immune response to the viral infection in general: i.e. whether naturally acquired, or through controlled vaccination. Natural infections were, naturally focused upon, in order to understand the baseline dynamics of viral infection. Reference [2] is...it says just as much about the efficacy of vaccination as the efficacy of natural immunity: > The cumulative incidence of SARS-CoV-2 infection remained almost zero among previously infected unvaccinated subjects, previously infected subjects who were vaccinated, and previously uninfected subjects who were vaccinated, compared with a steady increase in cumulative incidence among previously uninfected subjects who remained unvaccinated. Read reference [3] to understand why natural immunity doesn't cut it. Note that widespread natural immunity causes the same positive selection pressure as widespread vaccine deployment, and: > Finally, our work suggests that immune evasion requiring one to two mutations occurs within months, raising the prospect that this phenomenon will further shorten the duration of natural immunity... The paper goes on to provide (under Discussion) a series of strategies for developing a vaccination system that takes into account modelled viral evolution. Can't come up with strategies like that for natural immunity, apart from: "periodically re-infect individual"...which is exactly what vaccines do, in a controlled manner. Reference [4] and [5] are research tabulating mutations the virus is undergoing to counter both natural acquired and vaccine-mediated immune responses. It is not an indictment against vaccines, but just like paper [3], provide strategies on how to update vaccines. That updates will be required is not a surprise to anyone. Viral evolution has long been known of, and no one expected the emergency COVID-19 vaccines to be effective until the end of time. Reference [6]...did you read it? It's about vaccines which protect the host(keep them alive), but still keep them infectious (capable of transmission). None of the COVID-19 vaccines do that...
- criticaltinker 5y agoAre you trying to refute the claim that natural infection confers immunity that is at least equally as protective as vaccination? It's not clear to me that you've presented any counter evidence. I will try to outline my thoughts on your comment to help the discussion. [1] is another primary source beyond the OP that demonstrates the durability of the immune response from natural infection. We are in agreement that in principle the immune response from vaccination should also be durable due to relying on the same underlying mechanisms of the immune system - in fact I am unaware of any literature which demonstrates otherwise. So your point about [1] doesn't seem particularly relevant to me. > Reference [2] is...it says just as much about the efficacy of vaccination as the efficacy of natural immunity Yes you're right, and that is a relevant quote you pulled from the abstract. Again, I think we're actually in agreement here - the findings support my original claims. > Read reference [3] to understand why natural immunity doesn't cut it. Note that widespread natural immunity causes the same positive selection pressure as widespread vaccine deployment You seem to be missing the central thesis of [3], here are the relevant excerpts: - "The spike protein receptor-binding domain (RBD) of SARS-CoV-2 is the molecular target for many vaccines and antibody-based prophylactics aimed at bringing COVID-19 under control." - "Such a narrow molecular focus raises the specter of viral immune evasion as a potential failure mode for these biomedical interventions. With the emergence of new strains of SARS-CoV-2 with altered transmissibility and immune evasion potential, a critical question is this: how easily can the virus escape neutralizing antibodies (nAbs) targeting the spike RBD?" - "Our modeling suggests that SARS-CoV-2 mutants with one or two mildly deleterious mutations are expected to exist in high numbers due to neutral genetic variation, and consequently resistance to vaccines or other prophylactics that rely on one or two antibodies for protection can develop quickly -and repeatedly- under positive selection." - "The speed at which nAb resistance develops in the population increases substantially as the number of infected individuals increases, suggesting that complementary strategies to prevent SARS-CoV-2 transmission that exert specific pressure on other proteins (e.g., antiviral prophylactics) or that do not exert a specific selective pressure on the virus (e.g., high-efficiency air filtration, masking, ultraviolet air purification) are key to reducing the risk of immune escape" - "Strategies for viral elimination should therefore be diversified across molecular targets and therapeutic modalities" We are in agreement [4] and [5] are not an indictment against vaccines - but again you seem to be missing the most important and highly relevant findings which support my claims. For example from [4]: - "The acquisition of the L452R substitution by multiple lineages across multiple continents, including the B.1.617.1 and B.1.617.2 lineages emerging in India (54), is suggestive of positive selection, which might result from the selective pressure of RBD-specific neutralizing Abs" - "Our data support that the SARS-CoV-2 NTD evolved a compensatory mechanism to form an alternative disulfide bond and that mutations of the S signal peptide occur in vivo in a clinical setting to promote immune evasion." - "Understanding the newly found mechanism of immune evasion in emerging SARS-CoV-2 variants, such as the signal peptide modification described herein, is as important as sequence surveillance itself to successfully counter the ongoing pandemic." For example from [5]: - "different individuals immunized with the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2) vaccines produce closely related, and nearly identical, antibodies." - "To avert selection and escape, antibody therapies should be composed of combinations of antibodies that target non-overlapping or highly conserved epitopes" - "We speculate that these mutations emerged in response to immune selection in individuals with nonsterilizing immunity." > Reference [6]...did you read it? It's about vaccines which protect the host(keep them alive), but still keep them infectious (capable of transmission). None of the COVID-19 vaccines do that... You are incorrect - the current spike protein focused mRNA based vaccines do not guarantee sterilizing immunity - that means you can be vaccinated yet still get infected and transmit the virus to others. Please cite your sources if you're going to make such claims.